Moreover, one β1AR agonist was recently found to decrease overall brain inflammation and lessen AD pathology in an aggressive AD mouse model (Ardestani et al, 2017), providing strong support that β‐adrenergic signaling plays a positive role in helping control AD‐related brain injury. The gene discussed is ADRB1; the disease is Alzheimer disease.